Safeguard Scientifics Q4 and Full-Year Financial Results Recap
This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5…
Posted by
This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5…
Posted by
The past two weeks were brought to you by the letters IPO. From Facebook’s well-documented filing to this week’s IPO price cuts, a flurry of…
Posted by
Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…
Posted by
We’ve talked about Enterprise 3.0 before—how the evolution of social media, big data, mobile technology, Internet of Things, and cloud computing are transforming the enterprise.…
Posted by
This week, Safeguard Scientifics’ life sciences team is in San Francisco attending J.P. Morgan’s 30th Annual Healthcare Conference, one of the healthcare industry’s largest annual meetings.…
Posted by
In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…
Posted by
Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious.…
Posted by
As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While…
Posted by
At Safeguard Scientifics, we offer our partner companies quality resources to promote their growth and help them recruit strong management teams for their future. We…
Posted by